Status:
RECRUITING
3T MRI in Patients With Deep Brain Stimulation (DBS)
Lead Sponsor:
University Health Network, Toronto
Conditions:
Neuro-Degenerative Disease
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Deep brain stimulation (DBS) is an established treatment for advanced Parkinson's disease, medically refractory tremor, dystonia and obsessive compulsive disorder. Several hypotheses driven DBS trials...
Detailed Description
This is a prospective cohort study that will enroll patients who are about to or have already undergone DBS electrode placement for a variety of disorders including, but not limited to Parkinson's dis...
Eligibility Criteria
Inclusion Criteria:
- Age between 18 and 85 years of age
- Participants must be planned to undergo, or have undergone implantation of DBS electrodes
- Participants must be able to understand the purpose of this research and must sign the informed consent form.
- Participants must understand that the role of this research is to enhance our understanding of brain functioning and that he/she will not directly or indirectly benefit from the study.
Exclusion Criteria:
- Participants who have serious cognitive or psychological impairments and cannot give informed consent.
- Participants who are unable to effectively or efficiently communicate, for example patients suffering from speech deficits (dysarthria, aphasia) or are non-English speaking.
Key Trial Info
Start Date :
June 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT03153670
Start Date
June 1 2017
End Date
December 1 2030
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Western Hospital
Toronto, Ontario, Canada, M5T2S8